Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/138981Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Parreira, P | |
| dc.creator | Monteiro, C | |
| dc.creator | Graça, V | |
| dc.creator | Gomes, J | |
| dc.creator | Maia, S | |
| dc.creator | Gomes, P | |
| dc.creator | Gonçalves, IC | |
| dc.creator | Martins, MCL | |
| dc.date.accessioned | 2022-01-10T09:58:49Z | - |
| dc.date.available | 2022-01-10T09:58:49Z | - |
| dc.date.issued | 2019 | |
| dc.identifier.issn | 2045-2322 | |
| dc.identifier.uri | https://hdl.handle.net/10216/138981 | - |
| dc.description.abstract | As we approach the end of the antibiotic era, newer therapeutic options, such as antimicrobial peptides (AMPs), are in urgent demand. AMP surface grafting onto biomaterials has been described as a good strategy to overcome problems associated with their in vivo stability. Helicobacter pylori is among the bacteria that pose greatest threat to human health, being MSI-78A one of the few bactericidal AMPs against this bacterium. Here, we report that MSI-78A grafted onto model surfaces (Self-Assembled Monolayers –SAMs), in a concentration of 30.3 ± 1.2 ng/cm2 determined by quartz crystal microbalance with dissipation (QCM-D), was able to kill, by contact, 98% of planktonic H. pylori in only 2 h. This fact was not verified against the control bacteria (Staphylococcus epidermidis), although the minimal inhibitory concentration (MIC) of MSI-78A in solution is much lower for S. epidermidis (2 µg/mL) than for H. pylori (64 µg/mL). Our results also demonstrated that, in opposite to other bacteria, H. pylori cells were attracted to ethylene glycol terminated (antiadhesive) surfaces, which can explain the high bactericidal potential of grafted MSI-78A. This proof of concept study establishes the foundations for development of MSI-78A grafted nanoparticles for gastric infection management within a targeted nanomedicine concept. | |
| dc.description.sponsorship | This article is a result of the project NORTE-01-0145-FEDER-00012, (NORTE 2020) and FCT/MCTES-through the UID/BIM/04293/2019, PTDC/CTM-BIO/4043/2014, UID/QUI/50006/2013 (LAQV-REQUIMTE) projects. Claudia Monteiro acknowledges FCT for the SFRH/BPD/79439/2011 grant. | |
| dc.language.iso | eng | |
| dc.publisher | Nature Publishing Group | |
| dc.relation | info:eu-repo/grantAgreement/FCT/5876/147218/PT | |
| dc.relation | info:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBPD%2F79439%2F2011/PT | |
| dc.relation.ispartof | Scientific Reports, vol.9(1):18212 | |
| dc.rights | openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.mesh | Antimicrobial Cationic Peptides / administration & dosage | |
| dc.subject.mesh | Biocompatible Materials / chemistry | |
| dc.subject.mesh | Bioengineering | |
| dc.subject.mesh | Drug Delivery Systems / methods | |
| dc.subject.mesh | Helicobacter Infections / drug therapy | |
| dc.subject.mesh | Helicobacter Infections / microbiology | |
| dc.subject.mesh | Helicobacter pylori / drug effects | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Microbial Sensitivity Tests | |
| dc.subject.mesh | Nanoparticles / chemistry | |
| dc.subject.mesh | Proof of Concept Study | |
| dc.subject.mesh | Quartz Crystal Microbalance Techniques | |
| dc.subject.mesh | Staphylococcus aureus / drug effects | |
| dc.subject.mesh | Stomach Diseases / drug therapy | |
| dc.subject.mesh | Stomach Diseases / microbiology | |
| dc.title | Surface Grafted MSI-78A Antimicrobial Peptide has High Potential for Gastric Infection Management | |
| dc.type | Artigo em Revista Científica Internacional | |
| dc.contributor.uporto | Instituto de Investigação e Inovação em Saúde | |
| dc.identifier.doi | 10.1038/s41598-019-53918-4 | |
| dc.relation.publisherversion | https://www.nature.com/articles/s41598-019-53918-4 | |
| Appears in Collections: | I3S - Artigo em Revista Científica Internacional | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 10.1038-s41598-019-53918-4.pdf | 2.37 MB | Adobe PDF | ![]() View/Open |
This item is licensed under a Creative Commons License
